Document is current

Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease

Crossref DOI link: https://doi.org/10.1183/16000617.0061-2017

Published Online: 2017-10-25

Published Print: 2017-12-31

Update policy: https://doi.org/10.1183/ers-crossmark-policy